Ankerstar Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$206 Buy
+8
New +$173 ﹤0.01% 932
2026
Q1
– Sell
-15
Closed -$402 – 967
2025
Q4
$402 Buy
+15
New +$386 ﹤0.01% 712

Other funds holding AMPH

Ankerstar Wealth's AMPH Position: Q3 2026 in Review

Ankerstar Wealth opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 8 shares worth $206. The stake represents ﹤0.01% of the portfolio and ranks #932 among its holdings. This is a return to the name: Ankerstar Wealth previously reported a position in AMPH as recently as Q4 2025.

Ankerstar Wealth first reported a position in AMPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $402 in Q4 2025. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Ankerstar Wealth held 8 shares of Amphastar Pharmaceuticals worth $206 as of Q3 2026.
  • Amphastar Pharmaceuticals was a new Ankerstar Wealth position in Q3 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #932 holding.
  • Ankerstar Wealth first reported a position in Amphastar Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Ankerstar Wealth's Amphastar Pharmaceuticals position peaked at $402 in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.